Evidence from several recent studies has indicated that the overexpression of DDIT4 is also an adverse factor in ovarian carcinoma [23], gastric cancer [43], and lung adenocarcinoma [44]. This evidence concerns the gene DDIT4 and lung adenocarcinoma.